ALL vs JANX · P/E 4.9, rev $18.60B vs rev $10.3M
The Allstate Corporation (ALL) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. JANX currently screens at market cap $1.49B.
Not investment advice. Open the ALL and JANX stock pages for the full models.
Not investment advice.